4
Changes in Ownership
Arbutus Biopharma Corp Filed Acc 0001447028-25-000072
Options or other derivatives
- President and CEO acquired 310,422 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Androski Lindsay · President and CEO
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-03-18 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +310,422 | 310,422 | D |
Loading xslF345X05/wk-form4_1742501306.xml…